Detralex and detragel drugs in the treatment of chronic venous disease-Reference-Cited by-同舟云学术

Detralex and detragel drugs in the treatment of chronic venous disease

Published:2023-12-26 Issue:3 Volume:9 Page:13-16
ISSN:2409-3750
Container-title:Clinical Medicine and Pharmacology
language:en
Short-container-title:

Author:

Novikova Mariya¹

Affiliation:

1. National Research University Higher School of Economics

Abstract

Chronic venous disease is one of the most discussed diagnoses in surgery and occurs in about 25-50% of the adult population. The high prevalence of chronic venous disease in our country underlines the importance of accurate and modern diagnosis of this pathology, the need to use treatment technologies that can be applied as widely as possible, not only by cardiovascular doctors, phlebologists, but also specialists in general surgery and even doctors of other specialties. The Detralex line of drugs was created for the treatment of venous diseases: varicose veins and hemorrhoids. Detralex helps to relieve pain, swelling and heaviness in the legs in chronic venous disease, and in addition, helps to eliminate the symptoms of both acute and chronic hemorrhoids: discomfort, pain and bleeding.

Publisher

Infra-M Academic Publishing House

Subject

General Medicine

Reference6 articles.

1. Селиверстов Е.И., Авакъянц И.П., Никишков А.С., Золотухин И.А. Эпидемиология хронических заболеваний вен, Флебология, 2016:10 (1):35-43, Seliverstov E.I., Avak'yanc I.P., Nikishkov A.S., Zolotuhin I.A. Epidemiologiya hronicheskih zabolevaniy ven, Flebologiya, 2016:10 (1):35-43

2. Савельев В.С., Кириенко А.И., Золотухин И.А., Селиверстов Е.И. Проспективное обсервационное исследование СПЕКТР: регистр пациентов с хроническими заболеваниями вен нижних конечностей, Флебология. 2012;6(1):4-9, Savel'ev V.S., Kirienko A.I., Zolotuhin I.A., Seliverstov E.I. Prospektivnoe observacionnoe issledovanie SPEKTR: registr pacientov s hronicheskimi zabolevaniyami ven nizhnih konechnostey, Flebologiya. 2012;6(1):4-9

3. Клинические рекомендации «Варикозное расширение вен нижних конечностей», 2021, 163 с., Klinicheskie rekomendacii «Varikoznoe rasshirenie ven nizhnih konechnostey», 2021, 163 s.

4. Zolotukhin I, Seliverstov E, Shevtsov Y, Avakiants IP, Nikishkov AS, Ta- tarintsev AM, Kirienko AI. Prevalence and risk factors for chronic venous disease in the general russian population. European Journal of Vascular and Endovascular Surgery. 2017;54(6):752-758. https://doi.org/10.1016/j.ejvs.2017.08.033, Zolotukhin I, Seliverstov E, Shevtsov Y, Avakiants IP, Nikishkov AS, Ta- tarintsev AM, Kirienko AI. Prevalence and risk factors for chronic venous disease in the general russian population. European Journal of Vascular and Endovascular Surgery. 2017;54(6):752-758. https://doi.org/10.1016/j.ejvs.2017.08.033

5. Лекарственные препараты в России: Справочник Видаль [Электронный ресурс]. - Электрон. дан. - Режим доступа: http://www.vidal.ru., Lekarstvennye preparaty v Rossii: Spravochnik Vidal' [Elektronnyy resurs]. - Elektron. dan. - Rezhim dostupa: http://www.vidal.ru.